Mycobacterium; Xenopi
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection (NCT06585020) | Centre Hospitalier Universitaire, Amiens | 2024-10-20 |
Track Mycobacterium; Xenopi automatically
Every clearance here is in the API, with alerts when new ones post.